CTHRC1 expression is increased in hepatocellular carcinoma (46, 47), melanoma (48) and breast cancer (49) and in several studies increased mRNA and protein expression in tumors was associated with poor disease prognosis and survival (46, 49–52). This evidence concerns the gene CTHRC1 and breast carcinoma.